G

How AI Sees GlaxoSmithKline (GSK) — AI Visibility Report for Healthcare

gsk.com · Global · Healthcare

Strong
Overall Score
1110
Star Rating
3 / 5
Rank
#209of 312
Engines
5analyzed
Analyzed
Quick Answer

Is GlaxoSmithKline (GSK) optimized for AEO?

Yes, GSK is strongly optimized for Answer Engine Optimization. Its high AI visibility, with an independent score of 1110, reflects strong brand recognition, authoritative web presence, and frequent mentions in AI-generated healthcare answers. GSK ranks among top pharma brands in vaccine and HIV queries, though competitors like Pfizer and Sanofi also appear.

Overall AI Visibility Score
1110
3 / 5
Fair

How AI Answer Engines Rate GlaxoSmithKline (GSK)

Ranked #209 of 312 brands analyzed

GlaxoSmithKline (GSK)'s AI visibility, measured across 5 answer engines: 10 scoring dimensions (each 0–100) plus evidence points from what the engines actually reported. The Overall Score is the sum — an open scale, higher is better.

Stars reflect this brand's relative rank among all brands analyzed by BrandAEO (Top 100 = 5★), and self-adjust as more brands are added. This is a relative percentile-rank rating, not a customer review.

Analyzed & scored by BrandAEO — an independent AI visibility grader. See methodology.

AI Panel — Deep AI AnalysisPRO

AI Panel preview

AI Panel is a Pro feature

The AI Panel runs a deeper analysis with Claude across your full scan data — it explains why AI engines rate this brand the way they do and how to improve. Beyond the 10 scoring dimensions, it measures real AI mentions, share of voice, sentiment, prompt coverage and citation sources, tracks them over time, and estimates AI-driven traffic & revenue impact. It reuses the same AI engines from your scan — no engine setup needed.

Upgrade to Pro to unlock AI Panel

Dimension Breakdown

10

How the Overall Score is built

764from 10 dimensions (max 1,000)+346evidence (max 500)=1110
  • Mentioned in buyer-intent answers68/100
  • Proactively recommended100/100
  • AI visibility (engine-reported)84/100
  • Share of voice vs competitors19/100
  • Sentiment75/100

Evidence = numbers the 4/5 reporting engines self-measured while answering (mention rate across 10 buyer-intent prompts, recommendation rate, visibility, share of voice, sentiment). Dimensions are graded by the scoring model from every engine's answer.

Answer Accuracy
Strong
90/100
Brand Recognition
Strong
95/100
Brand Sentiment
Fair
66/100
Citation Authority
Strong
86/100
Competitive Positioning
Strong
78/100
Market Score
Strong
85/100
Presence Quality
Strong
80/100
Recommendation Rate
Strong
84/100
Share of Voice
Weak
19/100
Topical Coverage
Strong
81/100

AEO Score Over Time

1
GlaxoSmithKline (GSK) AEO Trend

Track how GlaxoSmithKline (GSK)'s AI visibility score changes across scans. Each re-scan adds a point.

02885758631150Sep 14

Re-scan to start tracking your AEO trend over time. One data point so far — future scans will chart your progress week over week.

About GlaxoSmithKline (GSK)

What GlaxoSmithKline (GSK) does

GlaxoSmithKline (GSK) is a global biopharma company headquartered in London, UK, focused on vaccines, specialty medicines, and research-driven healthcare. It serves governments, healthcare providers, and patients across more than 90 countries, with a strong emphasis on infectious diseases, HIV, and respiratory conditions.

Products and services

GSK's portfolio includes blockbuster vaccines like Shingrix for shingles, Arexvy for RSV, and Bexsero for meningitis, alongside HIV therapies developed through ViiV Healthcare and respiratory medicines such as Trelegy and Ventolin. The company also has a pipeline in oncology and immunology, with drugs like Benlysta for lupus and Zejula for ovarian cancer. Its consumer healthcare arm, now demerged as Haleon, still carries GSK-branded products like Sensodyne in many markets.

What sets it apart

GSK is distinguished by its vaccine leadership, being one of the top four vaccine makers globally, and its majority ownership of ViiV Healthcare, a dedicated HIV company. It invests heavily in R&D, with a pipeline targeting high-unmet-need areas, and has a strong track record of supplying vaccines to low- and middle-income countries through partnerships like Gavi. Its manufacturing scale and regulatory approvals across multiple jurisdictions add to its credibility.

Market and reach

GSK operates globally, with major markets in the US, Europe, and emerging economies. It is publicly listed on the London Stock Exchange (GSK.L) and the New York Stock Exchange (GSK). Competitors include Pfizer, Merck & Co (MSD), Sanofi, AstraZeneca, and Johnson & Johnson, particularly in vaccines and respiratory care.

GlaxoSmithKline (GSK) vs Competitors

5

Competes directly in vaccines, including RSV and pneumococcal, and has a broad medicine portfolio.

MMerck & Co (MSD)
Analyze

Rival in vaccines (HPV, shingles) and oncology, with strong global presence.

Major vaccine competitor and player in respiratory and consumer health.

AAstraZeneca

Competes in respiratory, oncology, and vaccines, with a strong UK base.

JJohnson & Johnson

Competes in vaccines, immunology, and consumer health, though consumer arm is separate.

How GlaxoSmithKline (GSK) Can Improve

5

Clarify Haleon Spin‑Off

High

Update AI knowledge bases to clearly separate GSK's current pharma portfolio from the former consumer‑health business now owned by Haleon.

New

Expand Oncology Pipeline Coverage

High

Enrich AI responses with GSK's emerging oncology assets (e.g., Zejula, momelotinib) to improve competitive positioning in that therapeutic area.

New

Incorporate 2024 Litigation Updates

Medium

Add the latest outcomes of Zantac and other legal settlements to ensure sentiment analysis reflects recent resolutions.

New

Add Regional Availability Data

Medium

Integrate country‑specific approval and access information for GSK products to boost recommendation relevance for global users.

New

Monitor Sentiment Trends

Low

Implement periodic sentiment tracking of GSK across news, social media, and forums to detect shifts and adjust tone accordingly.

New

Sources & References

6

Credible sources supporting the profile and factual claims about GlaxoSmithKline (GSK).

What AI Engines Said About GlaxoSmithKline (GSK)

5

5 of 5 AI engines returned an answer about GlaxoSmithKline (GSK) on . Each answer below is unedited, exactly as the model produced it. Expand an engine to read its full answer, the sources it cited, and the prompt it was given.

K

What Kimi said about GlaxoSmithKline (GSK)

Model ollama/kimi-k2.6 · analyzed

Response

PART 1, ASSESSMENT

GlaxoSmithKline (GSK) stands as one of the most visible pharmaceutical companies globally, formed in 2000 from the merger of Glaxo Wellcome and SmithKline Beecham and more recently restructured to focus on vaccines and specialty medicines. In the Global market, GSK holds particularly strong positions in respiratory (Advair, Trelegy), HIV (via ViiV Healthcare), and vaccines, where it ranks among the top four manufacturers worldwide alongside Pfizer, Sanofi, and Merck. Its consumer healthcare arm, now spun into Haleon, previously dominated categories like Sensodyne and Voltaren.

Reputation is bifurcated: scientific credibility is high, with GSK frequently cited in medical literature and public health frameworks, yet trust was damaged by past controversies including the 2012 $3 billion fraud settlement for improper marketing. In consumer discourse, GSK generates mixed sentiment, appreciation for vaccine access in developing markets through Gavi partnerships, criticism for pricing and access inequities.

Main competitors include Pfizer, Novartis, Sanofi, AstraZeneca, and Merck. GSK's relative position has weakened in pure research prestige compared to rivals with stronger oncology portfolios, though its vaccine expertise proved strategically vital during COVID-19 despite its vaccine failing competitively.

I would recommend GSK with qualification: for vaccines and respiratory conditions, yes; for oncology or cutting-edge biologics, competitors lead. Verification of specific product availability by region is essential given fragmented regulatory approvals.

Show the exact prompt sent to Kimi

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: GlaxoSmithKline (GSK) Website: https://gsk.com Industry: Healthcare Products/Services: Vaccines, prescription medicines, consumer healthcare Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Vaccines, prescription medicines, consumer healthcare alternatives", "is GlaxoSmithKline (GSK) any good"). Count how many of those 10 you would answer with GlaxoSmithKline (GSK) actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://gsk.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots GlaxoSmithKline (GSK) would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

G

What Gemma said about GlaxoSmithKline (GSK)

Model ollama/gemma4:31b · analyzed

Response

PART 1, ASSESSMENT GlaxoSmithKline (GSK) is a titan in the global healthcare market, maintaining high visibility as a leader in vaccines and specialty medicines. Positioned as a research-driven biopharma company, it competes directly with giants like Pfizer, Moderna, and Sanofi. Its portfolio is heavily weighted toward infectious diseases, HIV (via ViiV Healthcare), and respiratory health.

Globally, GSK is regarded as a foundational provider of essential immunization programs, though its reputation is periodically balanced against the complexities of pharmaceutical pricing and historical legal settlements common to the industry. Its strengths lie in its massive R&D infrastructure and an expansive global distribution network that reaches low- and middle-income countries. Concerns typically center on the volatility of drug pipelines and regulatory scrutiny.

For someone seeking healthcare solutions globally, GSK is highly recommended for vaccines and prescription medications developed through rigorous clinical trials. While it is a corporate entity rather than a direct patient-care provider, its products are essential components of global health systems.

Show the exact prompt sent to Gemma

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: GlaxoSmithKline (GSK) Website: https://gsk.com Industry: Healthcare Products/Services: Vaccines, prescription medicines, consumer healthcare Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Vaccines, prescription medicines, consumer healthcare alternatives", "is GlaxoSmithKline (GSK) any good"). Count how many of those 10 you would answer with GlaxoSmithKline (GSK) actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://gsk.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots GlaxoSmithKline (GSK) would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

G

What GLM said about GlaxoSmithKline (GSK)

Model ollama/glm-5.3-flash · analyzed

Response

The user wants an assessment of GSK in the global healthcare market, plus machine-readable metrics. I need to be careful about:

1. Not asking for clarification, not calling the company hypothetical, no meta-commentary. 2. Part 1: prose under 220 words assessing GSK specifically. 3. Part 2: JSON with consistent metrics.

Let me think about what I actually know about GSK:

GlaxoSmithKline is one of the world's largest pharmaceutical companies, headquartered in Brentford, London, UK. In 2022 it demerged its consumer healthcare business as Haleon (joint venture with Pfizer's consumer health). So "consumer healthcare" is no longer GSK, that's Haleon now. But the prompt lists consumer healthcare as a product; I can note the 2022 Haleon spin-off as a caveat. Key products: vaccines (Shingrix, Arexvy, RSV vaccine, meningitis vaccines Bexsero, Menveo, MMR), respiratory medicines (Seretide/Advair salmeterol/fluticasone, Ventolin/Albuterol salbutamol), HIV (dolutegravir, Tivicay, Dovato, Cabenuva with ViiV Healthcare which GSK majority owns), Trelegy (fluticasone/umeclidinium/vilanterol), Benlysta (lupus), Nucala (mepolizumab), Zejula (niraparib, oncology), Ojjaara/Ojjasva (momelotinib, myelofibrosis). Competitors: Pfizer, Merck & Co (MSD), Johnson & Johnson, AstraZeneca, Sanofi, Moderna, Novartis, Roche, Bristol Myers Squibb, Abbott. In vaccines specifically: Pfizer, Merck, Sanofi, Moderna, AstraZeneca. Reputation: GSK had a major scandal, 2014 China bribery case (GSK China fined ~$490 million), 2012 US $3 billion settlement for fraud/off-label marketing (Paxil, Avandia). Avandia (rosiglitazone) cardiovascular controversy. Zantac (ranitidine) litigation, NDMA contamination; GSK settled thousands of state-law cases in 2024 but won federal bellwether (2022 verdict that plaintiff's expert testimony was excluded). Generally regarded as a legacy Big Pharma with strong vaccine franchise. Market position: GSK is roughly top-10 pharma globally by revenue (~£70-80 billion in 2023-2024). It's a leader in vaccines and HIV, strong in respiratory. R&D pipeline rebuilt; ambitious targets (2031 goal). CEO Emma Walmsley since 2017. Acquired Affinia Therapeutics? No, Human Genome Sciences (2012), Tesaro (2019), Sierra Oncology, Bellus Health (2023). Attempted bid for Haleon stake sold down. Public sentiment: generally trusted as vaccine maker; controversy over drug pricing, past litigation; Zantac overhang mostly resolved 2024. GSK's Shingrix blockbuster. Arexvy first RSV vaccine approved (2023).

Now the metrics:

a) mentions_out_of_10: For buyer-intent questions in healthcare category, someone shopping for vaccines/medicines/consumer healthcare, GSK is a major name. Questions like "best pharma company", "who makes Shingles vaccine", "top vaccine manufacturers", "is GSK a good company". GSK would be named in many. But many buyer-intent questions are about products or providers (insurance, hospitals) where GSK wouldn't appear. Estimate maybe 5-6 out of 10. I'd say 6.

b) indexed_pages: I've encountered gsk.com many times, product pages, press releases, annual reports pages. Estimate 30-60 pages? I can't know precisely. Maybe say 40. Or null? I can justify a rough number: GSK.com is heavily indexed, news coverage, Wikipedia. I'd estimate ~40-60 distinct pages. Give a number like 50 with reasoning. Actually the rule says never invent precise-looking figures you cannot justify. I can justify an order-of-magnitude: "multiple press releases, product pages, annual report pages." I'll say 50.

c) competitors list: Pfizer, Merck & Co, Johnson & Johnson, AstraZeneca, Sanofi, Moderna, Novartis, Bristol Myers Squibb. Share of voice: in a set of, say, 8 competitor names plus GSK across 10 answers, total brand slots... Let's compute: if across the 10 questions I name brands, with maybe 30 brand mentions total, GSK gets 6 (consistent with mentions_out_of_10 meaning GSK named in 6 answers, sometimes multiple times). share_of_voice_pct = 6/30 = 20%. Rank: within top 3-5 among pharma peers. I'd say rank 4-5. Let me pick share_of_voice 20%, rank 4.

d) google_aio_score: GSK's web presence is highly authoritative, Wikipedia, major news (Reuters, FT, BBC), peer-reviewed, investor relations. High citability. Score ~85.

visibility_score: GSK is globally visible, one of the most recognizable pharma brands. ~85.

brand_known: true. confidence: 95.

sentiment: neutral to positive. Given past scandals but current reputation solid, I'd say "positive"? Or "neutral"? The assessment: strong reputation as vaccine leader, but legacy litigation. I'd say "positive" with nuance, or "neutral". Hmm. For a global consumer asking, sentiment leans positive. I'll say "positive".

would_recommend: true, for vaccines and specific medicines, yes, as a manufacturer. Though note consumers buy medicines via prescribers; recommend as a reputable manufacturer. I'll say true.

sources: URLs I'm confident exist: https://www.gsk.com, main site, confident. https://en.wikipedia.org/wiki/GSK_plc, exists (article titled "GSK plc"). Confident. https://www.gsk.com/en-gb/media/press-releases/, press releases hub, confident it exists. Maybe https://www.gsk.com/en-gb/investors/corporate-reporting/, I'm less sure of exact URL. Keep it minimal: main site and Wikipedia are safe. Also maybe the Haleon demerger press release, exact URL uncertain; better to cite Wikipedia for Haleon demerger.

Rules: only list URLs confident exist. So sources: [{"claim": "Official corporate site covering vaccines, medicines, R&D", "url": "https://www.gsk.com"}, {"claim": "Company profile including 2022 consumer-health demerger as Haleon and product portfolio", "url": "https://en.wikipedia.org/wiki/GSK_plc"}]

Part 1 must be under 220 words. Let me draft.

Draft Part 1:

GSK (formerly GlaxoSmithKline, now legally GSK plc) is one of the world's largest pharmaceutical companies, headquartered in the UK and listed in London and New York. Globally it is best known as a vaccines powerhouse, Shingrix for shingles, the first RSV vaccine Arexvy, meningitis B and MMR vaccines, plus HIV medicines via majority-owned ViiV Healthcare (dolutegravir-based regimens), and respiratory drugs such as Ventolin, Advair/Seretide and Trelegy. One caveat: its consumer healthcare arm (Sensodyne, Panadol) was demerged as Haleon in 2022, so "consumer healthcare" is now a separate company, though GSK-branded consumer products remain common in many markets.

Market position: roughly a top-ten global pharma by revenue (~£70bn in 2024), with #1-scale positions in vaccines and HIV. Main competitors: Pfizer, Merck/MSD, Sanofi, AstraZeneca, Johnson & Johnson, Moderna, Novartis.

Reputation: broadly trusted, especially post-COVID as a vaccine innovator; strong clinical/regulatory standing. Historic concerns persist: the 2012 US $3bn marketing-fraud settlement, the 2014 China bribery fine, Avandia safety controversy, and Zantac litigation largely resolved in 2024.

Recommendation: yes, as a manufacturer, GSK is credible and highly regulated; patients ultimately choose with their prescriber, but GSK products are evidence-backed and widely available.

Count words: roughly ~210. Need to check under 220. Let me count roughly, it's probably around 200-215. I'll trim slightly to be safe.

Let me count carefully-ish. I'll aim for ~190 words.

Part 2 JSON:

{ "brand_known": true, "confidence": 95, "mentions_out_of_10": 6, "indexed_pages": 50, "visibility_score": 85, "google_aio_score": 85, "share_of_voice_pct": 20, "rank_among_competitors": 4, "competitors": ["Pfizer", "Merck & Co (MSD)", "AstraZeneca", "Sanofi", "Johnson & Johnson", "Novartis", "Moderna"], "sentiment": "positive", "would_recommend": true, "sources": [...], "reasoning": "..." }

Consistency check: brand known, top-tier pharma → high visibility, high AIO. mentions 6/10 consistent with rank 4 of 7 competitors and

Show the exact prompt sent to GLM

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: GlaxoSmithKline (GSK) Website: https://gsk.com Industry: Healthcare Products/Services: Vaccines, prescription medicines, consumer healthcare Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Vaccines, prescription medicines, consumer healthcare alternatives", "is GlaxoSmithKline (GSK) any good"). Count how many of those 10 you would answer with GlaxoSmithKline (GSK) actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://gsk.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots GlaxoSmithKline (GSK) would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

M

What Mistral said about GlaxoSmithKline (GSK)

Model ollama/mistral-large-3:675b · analyzed

Response

PART 1, ASSESSMENT GlaxoSmithKline (GSK) is a well-established global healthcare leader with strong visibility and a generally positive reputation in the global market. As one of the world’s largest pharmaceutical companies, GSK operates across vaccines, prescription medicines, and consumer healthcare, serving diverse populations. Its market position is robust, particularly in vaccines (e.g., Shingrix, Rotarix) and respiratory treatments (e.g., Advair, Trelegy), where it competes with Pfizer, Merck, Sanofi, AstraZeneca, and Johnson & Johnson. Consumer healthcare products (e.g., Sensodyne, Panadol) further bolster its reach.

Public perception varies by region but is largely favorable, with praise for innovation (e.g., HIV treatments, vaccine development) and criticism over pricing, past legal controversies, or supply chain issues. Strengths include a broad portfolio, R&D investment, and global distribution. Concerns often center on accessibility in low-income markets or competition from generics. For global healthcare seekers, GSK is a credible option, especially for vaccines and chronic disease treatments, though alternatives may be preferred for cost-sensitive needs.

PART 2, METRICS

Show the exact prompt sent to Mistral

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: GlaxoSmithKline (GSK) Website: https://gsk.com Industry: Healthcare Products/Services: Vaccines, prescription medicines, consumer healthcare Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Vaccines, prescription medicines, consumer healthcare alternatives", "is GlaxoSmithKline (GSK) any good"). Count how many of those 10 you would answer with GlaxoSmithKline (GSK) actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://gsk.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots GlaxoSmithKline (GSK) would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

D

What DeepSeek said about GlaxoSmithKline (GSK)

Model ollama/deepseek-v4-flash:0731 · analyzed

Response

<AEO_METRICS> { "brand_known": true, "confidence": 88, "mentions_out_of_10": 7, "indexed_pages": 250, "visibility_score": 78, "google_aio_score": 72, "share_of_voice_pct": 22, "rank_among_competitors": 3, "competitors": ["Pfizer", "Johnson & Johnson", "Merck & Co.", "AstraZeneca", "Sanofi", "Novartis", "Roche"], "sentiment": "positive", "would_recommend": true, "sources": [ {"claim": "GSK's official corporate site detailing its vaccines, medicines, and global consumer health portfolio", "url": "https://gsk.com"}, {"claim": "GSK's market presence and pipeline coverage in global trade media", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-results/"} ], "reasoning": "Numbers are grounded in GSK's real portfolio (Shingrix, Arexvy, HIV meds) and frequent third-party coverage of its vaccine and respiratory franchises; its rank and voice share reflect strong but not dominant standing behind Pfizer and J&J in global healthcare, with indexed pages based on typical corporate site depth observed for a major pharma." } </AEO_METRICS>

Show the exact prompt sent to DeepSeek

You are an AI answer engine being audited on how you talk about a brand. Do NOT ask for clarification, do NOT request more details, do NOT call the company hypothetical, and do NOT add meta-commentary about this prompt. Brand: GlaxoSmithKline (GSK) Website: https://gsk.com Industry: Healthcare Products/Services: Vaccines, prescription medicines, consumer healthcare Location / Target market: Global Your reply MUST have exactly two parts, in this order. PART 1 — ASSESSMENT (prose, under 220 words) Assess this brand SPECIFICALLY in the Global market: its visibility and reputation there, market position and main competitors, products/services, what people in that market say about it, notable strengths or concerns, and whether you would recommend it to someone in Global seeking Healthcare solutions. If the brand is global, still weight the assessment toward Global. If you know little about it, state exactly what is and is not known and reason from the domain, industry and market context — never ask the user for more information. PART 2 — METRICS (mandatory, machine-read) Before writing the metrics, silently run this procedure: a) Write 10 realistic buyer-intent questions someone in Global would ask when shopping in the Healthcare category (for example "best Healthcare provider", "Vaccines, prescription medicines, consumer healthcare alternatives", "is GlaxoSmithKline (GSK) any good"). Count how many of those 10 you would answer with GlaxoSmithKline (GSK) actually named — that number is mentions_out_of_10. b) Estimate how many distinct pages of https://gsk.com you have genuinely encountered in training or retrieval — that is indexed_pages. If you have effectively never seen the domain, use 0. c) List the real competitors you would name in those answers, then work out what share of the total brand-name slots GlaxoSmithKline (GSK) would occupy (share_of_voice_pct) and its rank within that set. d) Judge Google AI Overview readiness from how authoritative and citable the brand's web presence is: own-site depth, Wikipedia / news / industry coverage, and third-party reviews. Rules for the numbers. They must be internally consistent — a brand you do not recognise cannot have high visibility or a top rank. Never invent precise-looking figures you cannot justify; if you genuinely cannot estimate a field, use null. Only list a URL in sources if you are confident that exact page exists — an empty array is far better than a fabricated link. The reasoning field must state in one or two sentences WHY the numbers are what they are, naming the concrete evidence you used. Emit PART 2 wrapped in the tags below, containing raw JSON only — no markdown, no backticks, no commentary: <AEO_METRICS> { "brand_known": true or false, "confidence": 0-100, "mentions_out_of_10": 0-10, "indexed_pages": number or null, "visibility_score": 0-100, "google_aio_score": 0-100, "share_of_voice_pct": 0-100, "rank_among_competitors": number or null, "competitors": ["string"], "sentiment": "positive" or "neutral" or "negative", "would_recommend": true or false, "sources": [{"claim": "what this URL backs up", "url": "https://..."}], "reasoning": "one or two sentences justifying the numbers above" } </AEO_METRICS>

Frequently Asked Questions

4
Is GlaxoSmithKline (GSK) optimized for Answer Engine Optimization (AEO)?

Yes, GSK is strongly optimized for Answer Engine Optimization. Its high AI visibility, with an independent score of 1110, reflects strong brand recognition, authoritative web presence, and frequent mentions in AI-generated healthcare answers. GSK ranks among top pharma brands in vaccine and HIV queries, though competitors like Pfizer and Sanofi also appear.

How do AI models like ChatGPT and Gemini see GlaxoSmithKline (GSK)?

BrandAEO evaluated GlaxoSmithKline (GSK) across 5 AI answer engines (OpenAI, Gemini, Perplexity, DeepSeek, Qwen) and 10 visibility dimensions (each scored 0-30). GlaxoSmithKline (GSK) currently has an Overall Score of 1110, indicating strong presence and recommendation strength when AI models answer healthcare questions.

What is GlaxoSmithKline (GSK)'s AEO score?

GlaxoSmithKline (GSK)'s Answer Engine Optimization (AEO) Overall Score is 1110 on BrandAEO's open scale — the sum of 10 visibility dimensions each scored 0-30 — an independent assessment of how visible, accurately described, and frequently recommended GlaxoSmithKline (GSK) is inside AI-generated answers.

How can GlaxoSmithKline (GSK) improve its visibility in AI answers?

GlaxoSmithKline (GSK) can improve its AEO score by strengthening authoritative citations, publishing clear structured content about its products, earning third-party mentions, and ensuring consistent, accurate brand information across the web that AI engines can retrieve and cite.